Growth Metrics

Erasca (ERAS) Research & Development (2020 - 2026)

Erasca posted quarterly Research & Development of $27.3 million for Q1 2026, up 4.99% year-on-year from $26.0 million in Q1 2025, and up 17.31% on a QoQ basis from $23.2 million in Q4 2025.

Erasca (ERAS) has 7 years of Research & Development data on file, last reported at $27.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 4.99% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $94.1 million (down 16.5% YoY), and the FY2025 full-year result was $92.9 million, down 19.51% from the prior year.
  • Research & Development for Q1 2026 stood at $27.3 million, up from $23.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $33.0 million in Q2 2024 and bottomed at $21.2 million in Q2 2025.
  • The 5-year median for Research & Development is $27.3 million (2026), against an average of $26.6 million.
  • The widest annual swing landed in 2022, when Research & Development jumped 124.0%; it then slumped 35.91% in 2025.
  • A 5-year view of Research & Development shows it stood at $29.4 million in 2022, then fell by 15.5% to $24.8 million in 2023, then advanced by 5.31% to $26.1 million in 2024, then retreated by 11.03% to $23.2 million in 2025, then increased by 17.31% to $27.3 million in 2026.
  • The last three Research & Development figures came in at $27.3 million (Q1 2026), $23.2 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 626,092.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.32 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -101.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 1.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 961.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -2.30 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.54 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 364.87 Mn
10 Erasca 4.21 Bn 3.97 Bn - 27.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.27 Mn
Dec 31, 2025 23.24 Mn
Sep 30, 2025 22.47 Mn
Jun 30, 2025 21.17 Mn
Mar 31, 2025 25.97 Mn
Dec 31, 2024 26.12 Mn
Sep 30, 2024 27.63 Mn
Jun 30, 2024 33.03 Mn
Mar 31, 2024 28.57 Mn
Dec 31, 2023 24.81 Mn
Sep 30, 2023 25.21 Mn
Jun 30, 2023 26.22 Mn
Mar 31, 2023 27.59 Mn
Dec 31, 2022 29.36 Mn
Sep 30, 2022 28.18 Mn
Jun 30, 2022 27.49 Mn
Mar 31, 2022 27.43 Mn
Dec 31, 2021 24.13 Mn
Sep 30, 2021 19.95 Mn
Jun 30, 2021 17.60 Mn
Mar 31, 2021 12.25 Mn
Dec 31, 2020 10.07 Mn
Sep 30, 2020 9.07 Mn
Jun 30, 2020 5.86 Mn